Palo Alto, California – February 13, 2024 – LVIS Corporation, a leading innovator in healthcare technology, is pleased to announce its participation in the upcoming 2024 American Clinical Neurophysiology Society (ACNS) Meeting in Orlando, Florida, from February 29 to March 2, 2024. The company will present its latest product, NeuroMatch®, designed to improve patient care by assisting specialists in understanding neural networks.
NeuroMatch® represents a significant advancement for LVIS Corporation in offering doctors and healthcare professionals a state-of-the-art tool to enhance their ability to diagnose and treat patients. The software suite provides accessible and secure tools to review EEG signal patterns.
David Cash, Chief Executive Officer at LVIS Corporation, stated, “NeuroMatch is designed to improve patient care by providing valuable insights into brain networks. We look forward to engaging with healthcare professionals at the 2024 American Clinical Neurophysiology Society.”
Attendees of the ACNS Meeting are encouraged to visit LVIS Corporation’s booth number 115 to learn more about NeuroMatch®.
Event Details:
- Date: February 29, 2024, to March 2, 2024
- Location: Orlando, Florida
- Booth Number: 115
For more information about LVIS Corporation and NeuroMatch®, please visit our website at (www.lviscorp.com) or contact us at contact@lviscorp.com
About LVIS Corporation:
LVIS Corporation, headquartered in Palo Alto, California, is a pioneering healthcare technology company dedicated to improving patient care and outcomes. With a strong focus on innovation and cutting-edge technologies, LVIS Corporation strives to develop solutions that make a significant difference in brain healthcare.
Contact:
LVIS Corporation
Email: contact@lviscorp.com Website: www.lviscorp.com